Seth A. Hollander

ORCID: 0000-0002-0818-3150
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Mechanical Circulatory Support Devices
  • Transplantation: Methods and Outcomes
  • Cardiac Structural Anomalies and Repair
  • Renal Transplantation Outcomes and Treatments
  • Congenital Heart Disease Studies
  • Cardiac Arrest and Resuscitation
  • Heart Failure Treatment and Management
  • Organ Transplantation Techniques and Outcomes
  • Acute Kidney Injury Research
  • Adolescent and Pediatric Healthcare
  • Ethics and Legal Issues in Pediatric Healthcare
  • Cardiac pacing and defibrillation studies
  • Cardiac Arrhythmias and Treatments
  • Family and Patient Care in Intensive Care Units
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Polyomavirus and related diseases
  • Cardiomyopathy and Myosin Studies
  • Pulmonary Hypertension Research and Treatments
  • Congenital Anomalies and Fetal Surgery
  • Childhood Cancer Survivors' Quality of Life
  • Palliative Care and End-of-Life Issues
  • Pneumonia and Respiratory Infections
  • Respiratory viral infections research
  • Viral Infections and Immunology Research
  • Cardiac electrophysiology and arrhythmias

Stanford University
2016-2025

Stanford Medicine
2012-2025

Lucile Packard Children's Hospital
2013-2024

Palo Alto University
2014-2024

Boston Children's Hospital
2017-2024

RELX Group (United States)
2023

Pediatrics and Genetics
2014-2020

Alberta Hospital Edmonton
2020

Harvard University
2017

Palo Alto Institute
2016

ABSTRACT Introduction Intraoperative gross liver inspection at the time of transplant can be used in determination which failing Fontan patients should undergo heart‐only transplantation (HT) versus combined heart–liver (CHLT). We describe outcomes listed for CHLT who underwent HT based on pathology transplant. Case Report Six patients, ages 15 (IQR12,16) years, received because reassuring findings All survived to hospital discharge, after median length stay 59 (IQR 42–77) days. Vasoplegia,...

10.1111/petr.70036 article EN Pediatric Transplantation 2025-01-27

We hypothesized that children with dilated cardiomyopathy who require hospital admission are at increased risk for death or transplantation during their first hospitalization and in the year follows. also assessed value of routine data collected time to predict need prior discharge within 1 admission.We conducted a retrospective review 83 pediatric patients whose initial fell between 2004 2009. The mean age was 7 years. majority demonstrated moderate severe left ventricular dysfunction on...

10.1161/circheartfailure.111.964510 article EN Circulation Heart Failure 2012-05-09

Despite increasing use of mechanical circulatory support in children, experience with biventricular device implantation remains limited. We describe our using the HeartWare HVAD to provide three patients and compare these five supported left ventricular assist (LVAD). At end study period, all (BiVAD) had been transplanted were alive. LVAD out bed ambulating a median 10.5 days postimplantation. The BiVAD 31 Pediatric both heart failure can be successfully bridged transplantation HVAD. Rapid...

10.1097/mat.0000000000000356 article EN ASAIO Journal 2016-02-26

Background Children with Down syndrome (DS) have a high risk of cardiac disease that may prompt consideration for heart transplantation (HTx). However, in patients DS is rarely reported. This project aimed to collect and describe waitlist post- HTx outcomes children DS. Methods Results retrospective case series listed HTx. Pediatric centers were identified by their participation 2 international registries reporting patient providing detailed demographic, medical, surgical, posttransplant...

10.1161/jaha.121.024883 article EN cc-by-nc-nd Journal of the American Heart Association 2022-05-16

Those diagnosed with PKU in the early years of newborn screening (NBS) were often discharged from clinic childhood. Long-term lost to patients may be impacted by untreated and uninformed about current recommendations. We aimed contact adults away for 5-50+ years, share recommendations, offer clinical care, elicit factors underlying not returning clinic.

10.1016/j.ymgmr.2024.101099 article EN cc-by Molecular Genetics and Metabolism Reports 2024-06-08

OBJECTIVE: Pediatric deaths often occur within hospitals and involve balancing aggressive treatment with minimization of suffering. This study first investigated associations between clinical/demographic features the level intensity various therapies these patients undergo at end life (EOL). Second, work used data to develop a new, broader spectrum for classifying pediatric EOL trajectories. DESIGN: Retrospective, single-center study, 2013–2021. SETTING: Four hundred sixty-one bed tertiary,...

10.1097/pcc.0000000000003579 article EN Pediatric Critical Care Medicine 2024-07-18

Outpatient experience of children supported with continuous-flow ventricular assist devices (CF-VAD) is limited. We reviewed our discharged CF-VAD support. All pediatric patients <18 years old CF-VADs implanted at institution were included. Discharge criteria included a stable medication regimen, completion VAD education program and standardized rehabilitation plan, presence caregiver. Hospital readmissions (excluding scheduled admissions) reviewed. Adverse events defined by Interagency...

10.1097/mat.0000000000000324 article EN ASAIO Journal 2015-12-31

To evaluate associations between haemodynamic profiles and symptoms, end-organ function outcome in children listed for heart transplantation.Children <18 years transplant 1993 2013 with cardiac catheterization data [pulmonary capillary wedge pressure (PCWP), right atrial (RAP), index (CI)] the Pediatric Heart Transplant Study database were included. Outcomes New York Association (NYHA)/Ross classification, renal hepatic dysfunction, death or clinical deterioration while on waitlist. Among...

10.1093/eurheartj/ehx456 article EN European Heart Journal 2017-07-19

Abstract Background The use of ventricular assist devices (VADs) in children with heart failure may be particular benefit to those accompanying renal failure, as improved function is seen some, but not all recipients. We hypothesized that persistent dysfunction at 7 days and/or 1 month after VAD implantation would predict chronic kidney disease (CKD) year transplantation (HT). Methods Linkage analysis patients enrolled both the PEDIMACS and PHTS registries between 2012 2016. Persistent acute...

10.1111/petr.13477 article EN Pediatric Transplantation 2019-05-24

This study's objective was to investigate compassionate ventricular assist device deactivation (VADdeact) in children from the perspective of pediatric heart failure provider.Pediatric VAD use is a standard therapy for advanced failure. Serious adverse events may affect relative benefit continued support, leading consideration VADdeact. Perspectives and practices regarding VADdeact have been studied adults but not children.A web-based anonymous survey clinicians patients (<18 years) sent...

10.1111/petr.13359 article EN Pediatric Transplantation 2019-02-07
Coming Soon ...